Loading
F-Prime Capital
F-Prime Capital is the venture firm that grew out of Fidelity's own money. It invests in healthcare and technology companies, including cancer diagnostics and therapeutics, from seed to growth.
Overview
F-Prime Capital is a global venture capital firm with roots in Fidelity Investments, investing in healthcare, life sciences and technology companies from company formation to growth stage, with offices in Cambridge (Massachusetts), San Francisco and London. Its healthcare portfolio spans therapeutics, diagnostics, medical devices and health IT, and includes oncology companies at several stages. Portfolio links in OnCo are derived from the startup records that name it.
Portfolio
4Portfolio (4)
Filter the startups table| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Adela Toronto, CA | Startup | diagnostics | Series A 2023, $48M | |
| AvenCell Therapeutics Watertown, MA, US | Growth stage | cell therapy | Diffuse large B-cell lymphomaNon-Hodgkin lymphoma (all types)Acute myeloid leukaemia | Grant 2025, $40M |
| CHARM Therapeutics London, GB | Growth stage | biotech | Acute myeloid leukaemiaNPM1-mutated and KMT2A-rearranged acute myeloid leukaemia | Series B 2025, $80M |
| K36 Therapeutics Cambridge, MA, US | Startup | biotech | Multiple myelomaProstate cancer | Series B 2023, $70M |
Connected
4Similar pages
- CompanySR One
Shares CHARM Therapeutics and the tag vc.
- CompanyDeerfield Management
Shares Adela and the tag vc.
- CompanyOrbiMed
Shares Adela, CHARM Therapeutics and the tag vc.
- CompanyAtlas Venture
Shares K36 Therapeutics and the tag vc.
- CompanyKhosla Ventures
Shares CHARM Therapeutics and the tag vc.
- CompanyNovo Holdings
Shares AvenCell Therapeutics and the tag vc.
- CompanyRA Capital Management
Shares Adela and the tag vc.
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
fprimecapital.com · 1
A source that has moved or gone is reported by the weekly link check. /audit/